Home » Agreement Allows Pediatric HIV Drug to Be Sold at Low Cost to Countries in Need
Agreement Allows Pediatric HIV Drug to Be Sold at Low Cost to Countries in Need
February 27, 2013
An agreement announced this morning between a UN-backed health organization and a partnership of three pharmaceutical companies will open the license for a pediatric HIV drug to be manufactured and sold at low cost to countries in need. The joint venture between Medicines Patent Pool and ViiV Healthcare — comprised of AIDS research units from GlaxoSmithKline, Pfizer and Shionogi — will let companies produce and sell the HIV drug abacavir in 118 countries.
The Jersey Journal
The Jersey Journal
Upcoming Events
-
21Oct